CD8A and neoplasm: Meanwhile, CXCR2, produced by tumors, induces neutrophil extracellular traps that interfere with immune cytotoxicity[37]; thus, inhibiting CXCR2 may significantly reduce neutrophil infiltration and enhance anti-tumor T cell activityvia promoting CD8 T cell activation[38].